Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
Screening high-risk groups could improve the survival of patients who develop myeloma.
Kellie Smith, 52, lives in Austin with her husband and child. She has multiple myeloma.
Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.
African Americans are twice as likely to be diagnosed with multiple myeloma as white people, but lag in treatment gains.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Those with blood cancers are nine times more likely to be hospitalized or die from the flu.
Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.
Having health insurance increases early detection and timely treatment for many cancers.
Incidence is increasing for six of 12 obesity-related cancers, including colorectal, kidney and pancreatic.
Less than 5 percent of Black patients were involved in trials for 24 out of 31 cancer drugs approved since 2015.
With the exception of colon cancer, most cancers associated with overweight or obesity rose over the past decade.
Trials of immunotherapy drug for multiple myeloma suspended after patient deaths.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.